HEALTH PROFESSIONAL · SOURCE READING

Adjuvant therapy

Source: Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 15, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Stages IA and IB NSCLC / Treatment Options for Stages IA and IB NSCLC

Many patients who have surgery subsequently develop regional or distant metastases.[9] Such patients are candidates for entry into clinical trials evaluating postoperative treatment with chemotherapy or radiation therapy following surgery. At present, neither chemotherapy nor radiation therapy has been found to improve survival in patients with stage I NSCLC that has been completely resected.

Source links and citations

Continue within this section

Adjuvant chemotherapy →Adjuvant targeted therapy (for patients with stage IB NSCLC and EGFR variants) →Adjuvant targeted therapy (for patients with stage IB tumors and ALK variants) →Adjuvant immunotherapy →Adjuvant external radiation therapy →Adjuvant brachytherapy →

Publication references

Read the original reference and check its publication notices.

PubMed 7815787 · Original source

Preserved source evidence · Not medical advice